Get started
HAMLET BIOPHARMA AB CLASS BHAMLET BIOPHARMA AB CLASS BHAMLET BIOPHARMA AB CLASS B

HAMLET BIOPHARMA AB CLASS B

No trades
See on Supercharts
Overview Financials
Documents
Discussions Technicals Seasonals

HAMLET BIOPHARMA AB CLASS B documents


Explore the latest documents from HAMLET BIOPHARMA AB CLASS B, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Data partner
Description
Reported date
Form
2025
Q4 2025
Aug 28, 2025
Interim report
Q3 2025
May 22, 2025
Interim report
Q2 2025
Feb 13, 2025
Interim report
Q1 2025
Nov 18, 2024
Interim report
2024
Q4 2024
Aug 28, 2024
Annual report
Interim report
Q3 2024
May 24, 2024
Interim report
Q2 2024
Feb 22, 2024
Interim report
Q1 2024
Nov 17, 2023
Interim report
2023
Q4 2023
Aug 28, 2023
Interim report
Q3 2023
May 26, 2023
Interim report
Q2 2023
Feb 23, 2023
Interim report
Q1 2023
Nov 11, 2022
Interim report
2022
Q4 2022
Aug 26, 2022
Interim report
Q3 2022
May 20, 2022
Interim report
Q2 2022
Feb 25, 2022
Interim report
Q1 2022
Nov 11, 2021
Interim report
2021
Q4 2021
Aug 26, 2021
Interim report